StonvexLoading…
StonvexStonvexStonvexCore line items from CTOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.45B | $1.36B | $1.33B | $1.08B |
Operating Income | $124.94M | $126.36M | $170.95M | $103.31M |
Net Income | $-31.05M | $-28.66M | $50.71M | $38.91M |
EPS (Diluted) | $-0.14 | $-0.12 | $0.21 | $0.16 |
Total Assets | $3.44B | $3.50B | $3.37B | $2.94B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $6.27M | $3.81M | $10.31M | $14.36M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 226.63M | 233.79M | 241.01M | 248.31M |